StreetAlpha.app
Home › Stocks › TMDX

TransMedics Group, Inc. (TMDX)

Healthcare
$85.25
▼ −9.33%
LAST CLOSE · NOV 20

TransMedics makes the Organ Care System, a portable device that keeps donor organs living outside the body for transplant. It last closed at $85.25 on Nov 20, down 9.33% on the day. The next earnings report for TMDX is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, TMDX reported EPS of $0.46 on revenue of $203.0M, with revenue up 41.1% from a year ago. Over its last 8 reports the stock moved an average of 12.2% the session after earnings. Over the last 12 months TMDX insiders bought $109K of stock on the open market and sold $4.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is TMDX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TMDX.

Key Stats

Last 12 months
Results
Revenue
$727.6M
+28.5% vs a year ago
Net income
$144.5M
+57.4% vs a year ago
EPS (diluted)
$3.67
+48.0% vs a year ago
Free cash flow
$44.7M
6.1% margin
Valuation
Market cap
$3.0B
34.7M shares
P/E
23.2
Price over 12 month EPS
Price to sales
4.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$511.4M
At Sep 30
Shareholder equity
$550.7M
Shares outstanding
34.7M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $30.3M$30.3MFY2021FY2022: $93.5M$93.5MFY2022FY2023: $241.6M$241.6MFY2023FY2024: $441.5M$441.5MFY2024FY2025: $605.5M$605.5MFY2025

From TMDX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · After the close
Reported EPS
$0.46
Quarter ended Sep 2026
Year ago EPS
$0.66
−30.3% on a GAAP basis
Revenue
$203.0M
+41.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.20Dec '24Mar 2025: $0.70Mar '25Jun 2025: $0.92Jun '25Sep 2025: $0.66Sep '25Dec 2025: $2.59Dec '25Mar 2026: $0.20Mar '26Jun 2026: $0.41Jun '26Sep 2026: $0.46Sep '26Latest $0.46
Revenue by quarter
Dec 2024: $121.6MDec '24Mar 2025: $143.5MMar '25Jun 2025: $157.4MJun '25Sep 2025: $143.8MSep '25Dec 2025: $160.8MDec '25Mar 2026: $173.9MMar '26Jun 2026: $189.9MJun '26Sep 2026: $203.0MSep '26Latest $203.0M
How TMDX moved after its last 8 reports
Average move the session after a report ±12.2%
Nov 5, 2026After the close+27.9%
Aug 4, 2026After the close−5.3%
May 5, 2026After the close−23.2%
Feb 24, 2026After the close−4.3%
Oct 29, 2025After the close+1.1%
Jul 30, 2025After the close+10.5%
May 8, 2025After the close+19.6%
Feb 27, 2025After the close+5.8%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TMDXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on TMDX: 0 upgrades, 0 downgrades, 0 initiations · Targets mentioned $80.00
Stifel NicolausNew target
Nov 21 $80.00

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on TMDX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TMDX

Technical Analysis

TMDX · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend

The stock is 5% above its 20 day and 5% above its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 52). The nearest support is the swing low (Sep 18) at $85.01, and the nearest resistance the Pivot at $86.92.

Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 6.2%/day
Key levels
$156.0052 week high+83.0%
$90.62200 day average+6.3%
$89.95Pivot R1+5.5%
$89.80Swing high (Sep 22)+5.3%
$86.92Pivot+2.0%
$85.25Last close
$85.01Swing low (Sep 18)−0.3%
$82.22Pivot S1−3.6%
$81.3220 day average−4.6%
$81.23100 day average−4.7%
$80.8850 day average−5.1%
$60.1052 week low−29.5%
Indicators
RSI (14)51.95Middle of its rangeNeutral
MACD4.38Above its signal lineBullish
Stochastic79.0Middle of its rangeNeutral
ADX (14)39.0Trending up
Williams %R-41.7Oversold below −80, overbought above −20Neutral
CCI (20)32.2Oversold below −100, overbought above 100Neutral
Rate of change−3.4%Change over 10 sessionsBearish
ATR (14)$5.31Typical daily range, 6.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for TMDX

What happened before

See how TMDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TMDX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TMDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TMDXHow many large options trades hit TMDX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

TMDX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●182 buying vs 184 selling
  • ▲Held by funds +4.2 pts
  • ▲Funds holding +8
  • ▼Superinvestors: 1 added, 2 cut
  • ▲Put/call 7.06 to 3.46
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding386378+2.1%
In funds' top 1021+100.0%
Held by funds104.5%100.3%+4.3 pts
New / increased58 / 12464 / 138−9.9%
Reduced / sold out131 / 53126 / 109−21.7%
Put/call ratio3.467.06−51.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TMDX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

TMDX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$109K1 buy · 1 insider
Sold$4.7M10 sales · 7 insiders
2025-12 sold $822K2026-03 sold $2.4M2026-06 sold $722K2026-09 bought $109K2026-11 sold $385KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 9James R TobinDirectorSale4,059$94.97$385K
Sep 11David WeillDirectorBuy1,336$81.63$109K
Jun 15Thomas J. GundersonDirectorSale9,624$75.06$722K
Mar 4David WeillDirectorSale3,571$146.82$524K
Mar 4Stephanie LovellDirectorSale1,193$149.62$178K
Mar 4Gerardo HernandezCFOSale7,611$146.81$1.1M
Every insider buy and sale for TMDX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See TMDX insider trades →

From SEC Form 4 filings by TMDX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMDX is in one of them and how their past TMDX trades turned out.

TMDX in the AI portfolios
Loading…

TMDX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TMDX in an article yet. Here's the latest on the wider market.

TMDX in the news

About TransMedics Group

TransMedics Group develops medical technology for organ transplants. Its Organ Care System is a portable device that keeps donor hearts, lungs and livers in a living state outside the body, using warm, oxygenated blood instead of cold storage. The company also runs a National OCS Program that handles organ procurement and aviation and ground transport for transplant centers across the United States. Its customers are mainly transplant centers and hospitals, and the company is based in Andover, Massachusetts.

Headquarters
Andover, MA